The Need to Address AMR Burden During COVID-19 Times

  09 July 2020

As per the World Health Organisation, only a small proportion of COVID-19 patients need antibiotics to treat subsequent bacterial infections and has issued guidance not to provide antibiotic treatment to patients with mild COVID-19 illness. However, people are consuming high doses of antibiotics as a precautionary measure when they feel symptoms like fever, cold and cough, without acknowledging that this could lead to antimicrobial resistance (AMR).

Further reading: ET Health World
Author(s): Patrick R Murray
Effective Surveillance  
Back


Technology Database

Display your AMR Technology, Product and Service

 

Suppliers and Users of Technologies, Products and Services benefit from CAPI.
CAPI (Continuous AMR Partnering Initiative) unites Suppliers and Users worldwide with the aim to add to the curbing of AMR.

 

Read more and make your own Technology Page >>
What is going on with AMR?
Stay tuned with remarkable global AMR news and developments!